Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal histamine itch challenge dose-finding study in healthy volunteers and atopic dermatitis
NL-OMON54996Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of histamine dihydrochloride and cetirizine in atopic dermatitis (AD) (2 arms), sponsored by Maruho Co., Ltd. Primary endpoints: Adverse events, Vital signs and 14 more. Started Dec 2019; status: completed.
02
Drugs
histamine dihydrochloridecetirizine
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NL-OMON54996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54996.